bluebird bio, Inc.
NASDAQ:BLUE
0.4865 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 29.497 | 3.597 | 3.662 | 250.734 | 44.674 | 54.579 | 35.427 | 6.155 | 14.079 | 25.421 | 20.181 | 0.34 | 0.882 |
| Cost of Revenue
| 33.527 | 10.077 | 38.857 | 5.396 | 2.978 | 0.885 | 1.527 | 204.775 | 123.738 | 62.574 | 31.002 | 17.21 | 0 |
| Gross Profit
| -4.03 | -6.48 | -35.195 | 245.338 | 41.696 | 53.694 | 33.9 | -198.62 | -109.659 | -37.153 | -10.821 | -16.87 | 0.882 |
| Gross Profit Ratio
| -0.137 | -1.802 | -9.611 | 0.978 | 0.933 | 0.984 | 0.957 | -32.27 | -7.789 | -1.462 | -0.536 | -49.618 | 1 |
| Reseach & Development Expenses
| 167.652 | 240.764 | 319.946 | 587.956 | 582.413 | 448.589 | 273.04 | 204.775 | 134.038 | 62.574 | 31.002 | 17.21 | 11.409 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 174.129 | 93.55 | 65.119 | 46.209 | 23.227 | 14.126 | 6.846 | 4.615 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 165.51 | 136.908 | 209.969 | 286.896 | 271.362 | 174.129 | 93.55 | 65.119 | 46.209 | 23.227 | 14.126 | 6.846 | 4.615 |
| Other Expenses
| 38.707 | -102 | 27.652 | -6.502 | -10.088 | 1.961 | -1.267 | 3.711 | 2.314 | 0.12 | 0 | 0 | 0 |
| Operating Expenses
| 240.232 | 275.672 | 529.915 | 874.852 | 853.775 | 622.718 | 366.59 | 269.894 | 180.247 | 85.801 | 45.128 | 24.056 | 16.024 |
| Operating Income
| -244.262 | -287.092 | -590.911 | -629.514 | -812.079 | -572.023 | -332.165 | -267.83 | -169.037 | -60.626 | -24.947 | -23.716 | -15.142 |
| Operating Income Ratio
| -8.281 | -79.814 | -161.363 | -2.511 | -18.178 | -10.481 | -9.376 | -43.514 | -12.006 | -2.385 | -1.236 | -69.753 | -17.168 |
| Total Other Income Expenses Net
| 38.707 | 20.631 | 28.531 | 11.505 | 21.926 | -1.038 | -0.742 | -0.38 | -0.555 | -0.126 | -0.403 | 0.041 | -0.461 |
| Income Before Tax
| -212.039 | -266.461 | -562.38 | -618.009 | -790.153 | -555.438 | -335.433 | -264.119 | -166.723 | -60.506 | -25.321 | -23.67 | -15.598 |
| Income Before Tax Ratio
| -7.188 | -74.079 | -153.572 | -2.465 | -17.687 | -10.177 | -9.468 | -42.911 | -11.842 | -2.38 | -1.255 | -69.618 | -17.685 |
| Income Tax Expense
| -0.126 | 0.117 | 0.258 | 0.686 | -0.545 | 0.187 | 0.21 | -0.612 | 0.06 | -11.797 | 0.374 | -0.046 | 0.456 |
| Net Income
| -211.913 | -266.578 | -562.638 | -618.695 | -789.608 | -555.625 | -335.643 | -263.507 | -166.783 | -48.709 | -25.321 | -23.67 | -15.598 |
| Net Income Ratio
| -7.184 | -74.111 | -153.642 | -2.468 | -17.675 | -10.18 | -9.474 | -42.812 | -11.846 | -1.916 | -1.255 | -69.618 | -17.685 |
| EPS
| -1.93 | -3.39 | -8.16 | -9.95 | -14.31 | -10.68 | -7.71 | -7.07 | -4.81 | -1.83 | -2.02 | -1.04 | -0.68 |
| EPS Diluted
| -1.93 | -3.39 | -8.16 | -9.95 | -14.31 | -10.68 | -7.71 | -7.07 | -4.81 | -1.83 | -2.02 | -1.04 | -0.68 |
| EBITDA
| -167.161 | -277.212 | -539.309 | -635.982 | -809.332 | -566.025 | -333.215 | -259.648 | -163.299 | -60.134 | -23.603 | -23.456 | -14.456 |
| EBITDA Ratio
| -5.667 | -77.068 | -147.272 | -2.536 | -18.116 | -10.371 | -9.406 | -42.185 | -11.599 | -2.366 | -1.17 | -68.988 | -16.39 |